Davis Robert M — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Davis Robert M has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $5.60M.
Profile
Robert M. Davis is the Chairman of the Board, Chief Executive Officer, and President of Merck & Co. (MRK), as disclosed in the most recent SEC filing dated 2026-01-28, where he is listed as a director and officer with no reported purchases or sales. He leads Merck’s global strategy and operations as the head of a global pharmaceutical company known for products across cardiometabolic, cancer, infectious disease, vaccines, and animal health, including Keytruda and Gardasil.
Robert M. Davis is the Chairman of the Board, Chief Executive Officer, and President of Merck & Co. (MRK), as disclosed in the most recent SEC filing dated 2026-01-28, where he is listed as a director and officer with no reported purchases or sales. He leads Merck’s global strategy and operations as the head of a global pharmaceutical company known for products across cardiomet…
How many SEC Form 4 filings has Davis Robert M submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Davis Robert M been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($5.60M) across all tracked filings.
Where can I see all of Davis Robert M's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
